%0 Journal Article %T Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC? %A Klevansky, Myron %A John, Thomas %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC? %K %X In an age of targeted therapies, the promise of eliminating non-targeted and indeed more toxic chemotherapy was considered a given until several trials challenged this assumption. %U https://jtd.amegroups.org/article/view/21053 %P S1986-S1988 %@ 2077-6624